Inbred mouse strains differ in their sensitivity to an antiseizure effect of MK-801

被引:0
作者
Deutsch, SI
Mastropaolo, J
Powell, DG
Rosse, RB
Bachus, SE
机构
[1] Dept Vet Affairs Med Ctr, Psychiat Serv 116A, Washington, DC 20422 USA
[2] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA
[3] NIMH, Clin Brain Disorders Branch, NIH, Neurosci Ctr & St Elizabeths, Washington, DC USA
关键词
MK-801; seizures; genetics;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The ability of MK-801 to antagonize the electrical precipitation of tonic hindlimb extension was studied in four inbred mouse strains (BALB/c, C57BL/6, AKR, and DBA/2) and the outbred NM Swiss strain, using an incremental electroconvulsive shock (IECS) procedure. Strains differed in the threshold voltages required for the electrical precipitation of tonic hindlimb extension. They also differed in their sensitivity to antagonism of electrically precipitated tonic hindlimb extension by MK-801. The BALB/c, C57BL, and DBA strains required a significant elevation of the threshold voltage for the elicitation of tonic hindlimb extension in response to 0.18 mg/kg of MK-801, the lowest dose tested; whereas the AKR and NIH Swiss strains did not respond to this dose with an increase of threshold voltage for the elicitation of tonic hindlimb extension. Moreover, a higher percentage of BALB/c mice were maximally protected against seizure elicitation by MK-801 over a dosage range of 0.18 to 0.56 mg/kg, compared to the other strains. The demonstration of strain differences suggests that genetic factors influence the anticonvulsant properties of MK-801.
引用
收藏
页码:255 / 257
页数:3
相关论文
共 7 条
[1]   DIFFERENT BINDING AFFINITIES OF NMDA RECEPTOR-CHANNEL BLOCKERS IN VARIOUS BRAIN-REGIONS - INDICATION OF NMDA RECEPTOR HETEROGENEITY [J].
BRESINK, I ;
DANYSZ, W ;
PARSONS, CG ;
MUTSCHLER, E .
NEUROPHARMACOLOGY, 1995, 34 (05) :533-540
[2]   Inbred mouse strains differ in sensitivity to ''popping'' behavior elicited by MK-801 [J].
Deutsch, SI ;
Rosse, RB ;
Paul, SM ;
Riggs, RL ;
Mastropaolo, J .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (1-2) :315-317
[3]  
LYNCH DR, 1994, MOL PHARMACOL, V45, P540
[4]   A GLYCINERGIC INTERVENTION POTENTIATES THE ANTISEIZURE EFFICACIES OF MK-801, FLURAZEPAM, AND CARBAMAZEPINE [J].
NORRIS, DO ;
MASTROPAOLO, J ;
OCONNOR, DA ;
COHEN, JM ;
DEUTSCH, SI .
NEUROCHEMICAL RESEARCH, 1994, 19 (02) :161-165
[5]   GLYCINERGIC INTERVENTIONS POTENTIATE THE ABILITY OF MK-801 TO RAISE THE THRESHOLD VOLTAGE FOR TONIC HINDLIMB EXTENSION IN MICE [J].
NORRIS, DO ;
MASTROPAOLO, J ;
OCONNOR, DA ;
NOVITZKI, MR ;
DEUTSCH, SI .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) :609-612
[6]   A REVIEW OF MOUSE MUTANTS AS GENETIC MODELS OF EPILEPSY [J].
SEYFRIED, TN ;
GLASER, GH .
EPILEPSIA, 1985, 26 (02) :143-150
[7]   DIFFERENT SENSITIVITIES OF NMDA RECEPTOR-CHANNEL SUBTYPES TO NONCOMPETITIVE ANTAGONISTS [J].
YAMAKURA, T ;
MORI, H ;
MASAKI, H ;
SHIMOJI, K ;
MISHINA, M .
NEUROREPORT, 1993, 4 (06) :687-690